IL10 and melanoma: Finally, we treated melanoma cells with dacarbazine, an alkylating chemotherapeutic agent, and found that drug-treated primary melanoma cells magnified the IL-10 elevating effect of MAFs on THP-1 cells (Figure 8b–d).